Cure For Copd 2024
Cure For Copd 2024. Winrevair was approved by the fda on tuesday to help treat pulmonary arterial hypertension. The new wave of potential therapies will bring a shift in the treatment paradigm for copd, according to globaldata, a leading data and analytics.
Winrevair is a biologic drug designed to. Transplanting patients’ own lung cells shows great promise.